DE69326122D1 - Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen - Google Patents
Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungenInfo
- Publication number
- DE69326122D1 DE69326122D1 DE69326122T DE69326122T DE69326122D1 DE 69326122 D1 DE69326122 D1 DE 69326122D1 DE 69326122 T DE69326122 T DE 69326122T DE 69326122 T DE69326122 T DE 69326122T DE 69326122 D1 DE69326122 D1 DE 69326122D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- igf
- gastrointestinal disorders
- growth factor
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 title abstract 3
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 title abstract 3
- 208000018522 Gastrointestinal disease Diseases 0.000 title abstract 2
- 239000003102 growth factor Substances 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 3
- 210000003022 colostrum Anatomy 0.000 abstract 1
- 235000021277 colostrum Nutrition 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 208000030212 nutrition disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ243071A NZ243071A (en) | 1992-06-08 | 1992-06-08 | Igf-2 (or analogue) compositions for pharmaceutical uses |
| PCT/SE1993/000503 WO1993025227A1 (en) | 1992-06-08 | 1993-06-07 | Use of growth factor igf-ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69326122D1 true DE69326122D1 (de) | 1999-09-30 |
Family
ID=19924004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69326122T Expired - Lifetime DE69326122D1 (de) | 1992-06-08 | 1993-06-07 | Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5482926A (de) |
| EP (1) | EP0602211B1 (de) |
| JP (1) | JPH06510066A (de) |
| AT (1) | ATE183651T1 (de) |
| AU (1) | AU670296B2 (de) |
| CA (1) | CA2114420A1 (de) |
| DE (1) | DE69326122D1 (de) |
| NZ (2) | NZ260309A (de) |
| WO (1) | WO1993025227A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN271295A0 (en) * | 1995-05-02 | 1995-05-25 | Gropep Pty Ltd | Method of treatment |
| JPH06510065A (ja) * | 1992-06-08 | 1994-11-10 | カイロン コーポレーション | 成長因子ｉｇｆ−ｉおよび／またはｉｇｆ−ｉｉの用法 |
| US5712249A (en) * | 1994-09-08 | 1998-01-27 | Ciba-Geigy Corporation | Use of insulin-like growth factors I and II for inhibition of inflammatory response |
| AU689719B2 (en) * | 1995-05-02 | 1998-04-02 | Novozymes Biopharma Dk A/S | Method of preventing or treating alimentary tract damage due to chemotherapy or radiation |
| US5814308A (en) * | 1996-03-26 | 1998-09-29 | Zhang; Ke | Methods for the treatment of gastrointestinal tract disorders |
| DE69719190D1 (de) * | 1996-07-02 | 2003-03-27 | Pharmaproducts Uk Ltd | Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung |
| US5952301A (en) * | 1996-12-10 | 1999-09-14 | 1149336 Ontario Inc. | Compositions and methods for enhancing intestinal function |
| US6051557A (en) * | 1997-05-16 | 2000-04-18 | 1149336 Ontario Inc. | Methods of enhancing functioning of the upper gastrointestinal tract |
| WO2001010448A1 (en) * | 1999-08-09 | 2001-02-15 | University Of Maryland, Baltimore | Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| KR102313381B1 (ko) * | 2013-12-19 | 2021-10-14 | 퓨어테인 바이오사이언스, 엘엘씨. | 동물을 치료하기 위한 방법 |
| CN106167789B (zh) * | 2015-05-21 | 2020-08-04 | 中国科学院上海营养与健康研究所 | 低氧处理的间充质干细胞及其应用 |
| CN108114271B (zh) * | 2016-11-29 | 2021-07-02 | 中国科学院上海营养与健康研究所 | 含胰岛素样生长因子-2的药物组合物及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2507106B2 (ja) * | 1987-12-24 | 1996-06-12 | グロペップ プロプライエタリー リミテッド | インスリン様成長因子１（ｉｇｆ―１）または因子２（ｉｇｆ―２）の類縁ペプチド |
| EP0429586B1 (de) * | 1989-06-09 | 1995-08-02 | Gropep Pty. Ltd. | Wachstumshormonfusionsproteine |
| DE69129267T2 (de) * | 1990-02-13 | 1998-09-10 | Gropep Pty. Ltd., Adelaide | Methode zur behandlung intestinaler krankheiten |
| NZ234439A (en) * | 1990-07-10 | 1997-08-22 | Pharmacia & Upjohn Ab | Use of igf-1 to reduce fetal growth retardation in non human mammals |
| IE912345A1 (en) * | 1990-08-03 | 1992-02-12 | Pharmacia Ab | Treatment of human lactation failure |
| SE9002732D0 (sv) * | 1990-08-24 | 1990-08-24 | Kabivitrum Ab | Product containing growth factor |
| SE9101840L (sv) * | 1991-06-14 | 1992-12-15 | Kabi Pharmacia | Ny medicinsk anvaendning |
-
1992
- 1992-06-08 NZ NZ260309A patent/NZ260309A/en unknown
- 1992-06-08 NZ NZ243071A patent/NZ243071A/en unknown
-
1993
- 1993-06-07 CA CA002114420A patent/CA2114420A1/en not_active Abandoned
- 1993-06-07 US US08/190,168 patent/US5482926A/en not_active Expired - Fee Related
- 1993-06-07 WO PCT/SE1993/000503 patent/WO1993025227A1/en active IP Right Grant
- 1993-06-07 DE DE69326122T patent/DE69326122D1/de not_active Expired - Lifetime
- 1993-06-07 AT AT93913735T patent/ATE183651T1/de not_active IP Right Cessation
- 1993-06-07 JP JP6501380A patent/JPH06510066A/ja active Pending
- 1993-06-07 EP EP93913735A patent/EP0602211B1/de not_active Expired - Lifetime
- 1993-06-07 AU AU43662/93A patent/AU670296B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU4366293A (en) | 1994-01-04 |
| EP0602211A1 (de) | 1994-06-22 |
| CA2114420A1 (en) | 1993-12-23 |
| ATE183651T1 (de) | 1999-09-15 |
| JPH06510066A (ja) | 1994-11-10 |
| EP0602211B1 (de) | 1999-08-25 |
| US5482926A (en) | 1996-01-09 |
| NZ243071A (en) | 1994-09-27 |
| WO1993025227A1 (en) | 1993-12-23 |
| NZ260309A (en) | 1997-07-27 |
| AU670296B2 (en) | 1996-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE164067T1 (de) | Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen | |
| ATE203165T1 (de) | Behandlung des partiellen wachstumshormon- unempfindlichkeitssyndromes | |
| EP1201241B8 (de) | Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum | |
| DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| ATE144420T1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
| DE69218948D1 (de) | IGF-I zur Verbesserung der neuronale Lage | |
| DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| ATE112684T1 (de) | Verwendung von igf-ii zur behandlung von knochenkrankheiten. | |
| ATE135208T1 (de) | Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen | |
| ATE183651T1 (de) | Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen | |
| ATE207351T1 (de) | Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden | |
| PT920323E (pt) | Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica | |
| DE60305055D1 (de) | Verwendung von ghrelin zur behandlung von unterernährung von gastrektomiepatienten | |
| ATE225803T1 (de) | Peptid zur verringerung des triglyzeridspiegels des blutes und inhibitor für den anstieg des triglyzeridspiegels des blutes, der das peptid als aktiven bestandteil enthält | |
| ATE152628T1 (de) | Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft | |
| DE68924006D1 (de) | Pharmazeutische Zusammensetzungen mit Eierschalenbestandteilen und ihre Herstellung und Verwendung. | |
| KR100488038B1 (ko) | 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도 | |
| ATE246511T1 (de) | Behandlung des partiellen wachstumshormon- unempfindlichkeitssyndroms | |
| DE69124382D1 (de) | Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| DE59410340D1 (de) | Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen | |
| ATE218869T1 (de) | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen | |
| Gluckman et al. | Growth factor IGF-IL | |
| NO940383L (no) | Anvendelse av vekstfaktor IGF-I og/eller IGF-II |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |